LightDark Log in Sign up

‹ Back to screener

CAPLIPOINT.NS Caplin Point Laboratories Ltd.

Healthcare

Price history

1M 6M 1Y 3Y Max
2021-08-23 ₹703.95
2026-08-21 ₹2547.30
Change over window +261.86%

Price is the daily close from stored Kite history. The other metrics pair that daily price with the company's periodic filings — each fundamental (revenue, EPS, equity…) is held flat at its latest filed value between annual filings, so a ratio steps at each filing and moves daily only through its price term. A metric with no input on file for this company (e.g. EV/EBITDA for a bank, which has no EBIT) is shown as unavailable, never guessed. Share-count-based metrics use the latest diluted share count against split/bonus-adjusted prices.

Technical indicators

ℹ These reflect only the stock's recent price and volume behavior — not the company's fundamentals — and are not a recommendation to buy or sell. Standard published parameters are used throughout (see each chart's own label); a company with too little stored price history for a given indicator's lookback window shows that plainly below rather than a garbage or misleading value.

MACD (12,26,9), Stochastic Oscillator (14,3) and Money Flow Index (14-day) each carry their own published reference lines/bands (20/80 for the oscillator readings) where one is standard. ADX includes +DI/-DI for direction alongside trend strength; a dashed line marks the commonly published 25 "trending market" reading. ATR is shown in raw rupees here; the price/volume preset screen (below, and on the Screener page) reports it as a % of price so it's comparable across stocks at different price levels. Computed from the same stored daily OHLCV history as the price chart above — no new data source.

Delivery volume

Latest (2026-08-28) 43.4%
Trailing 20-day average 47.4%
Date Traded Qty Delivery Qty Delivery %
2026-08-28 47400 20572 43.40%
2026-08-27 40296 19086 47.36%
2026-08-26 59944 31369 52.33%
2026-08-25 50538 22606 44.73%
2026-08-24 210240 87716 41.72%
2026-08-21 49778 26918 54.08%
2026-08-20 47100 21775 46.23%
2026-08-19 77302 39031 50.49%
2026-08-18 70633 32093 45.44%
2026-08-17 99795 42439 42.53%
2026-08-14 56745 27573 48.59%
2026-08-13 127525 43258 33.92%
2026-08-12 427821 110915 25.93%
2026-08-11 93909 52817 56.24%
2026-08-10 128452 68298 53.17%
2026-08-07 44432 22594 50.85%
2026-08-06 48098 25253 52.50%
2026-08-05 43064 23937 55.58%
2026-08-04 57214 31767 55.52%
2026-08-03 55647 25963 46.66%

Delivery quantity/percentage from the NSE bhavcopy (DELIV_QTY/DELIV_PER) — the share of that day's traded volume that actually settled into a demat account, rather than being squared off intraday. A higher delivery percentage is commonly read as genuine accumulation/distribution rather than speculative same-day trading; this describes recent trading PATTERN, not the company itself, and is not a recommendation to buy or sell. A blank cell is a day NSE itself published no figure for, never a zero. Run python manage.py refresh_delivery_volumes --tickers CAPLIPOINT.NS to fetch more history.

Insider trading activity

Disclosed Person Category Type Mode Quantity Value (₹) Resulting stake
24 Mar 2023 P Vijayalakshmi Promoter Group Buy Gift 898790 547363110 24.74% XBRL
24 Nov 2021 Arulsudar Natrajan Employees/Designated Employees Sell Market Sale 1500 1246500 0.00% XBRL
24 Nov 2021 Arulsudar Natrajan Employees/Designated Employees Sell Market Sale 2000 1664000 0.00% XBRL
24 Nov 2021 Satish Krishnan Employees/Designated Employees Sell Market Sale 5000 4057560 0.00% XBRL
19 Nov 2021 Arulsudar Natrajan Employees/Designated Employees Sell Market Sale 1500 1299075 0.00% XBRL
19 Nov 2021 Subramanian Narayanaswamy Employees/Designated Employees Sell Market Sale 100 87000 0.00% XBRL
19 Nov 2021 Subramanian Narayanaswamy Employees/Designated Employees Sell Market Sale 4900 4251975 0.00% XBRL
08 Nov 2021 Satish Kumar S Employees/Designated Employees Buy ESOP 4167 8334 0.01% XBRL
08 Nov 2021 Satish Krishnan Employees/Designated Employees Buy ESOP 5000 10000 0.01% XBRL
08 Nov 2021 Sathyanarayanan M Employees/Designated Employees Buy ESOP 5000 10000 0.01% XBRL
08 Nov 2021 Satish Kumar Rajendran Employees/Designated Employees Buy ESOP 5000 10000 0.01% XBRL
08 Nov 2021 Rubavanan C Employees/Designated Employees Buy ESOP 1667 3334 0.00% XBRL
08 Nov 2021 Raghavan C Employees/Designated Employees Buy ESOP 2500 5000 0.00% XBRL
08 Nov 2021 Saravana Raja S Employees/Designated Employees Buy ESOP 10000 20000 0.01% XBRL
08 Nov 2021 Sachin Dondiram Patil Employees/Designated Employees Buy ESOP 5000 10000 0.01% XBRL
08 Nov 2021 Pravin Babu S T Employees/Designated Employees Buy ESOP 3333 6666 0.00% XBRL
08 Nov 2021 Pramoth Narasimmhan Employees/Designated Employees Buy ESOP 3125 6250 0.00% XBRL
08 Nov 2021 Prabakaran T Employees/Designated Employees Buy ESOP 1667 3334 0.00% XBRL
08 Nov 2021 Venkataraju M P Employees/Designated Employees Buy ESOP 2500 5000 0.00% XBRL
08 Nov 2021 Balaji G Employees/Designated Employees Buy ESOP 2500 5000 0.00% XBRL

SEBI PIT (Prohibition of Insider Trading) Regulation 7 disclosures — designated persons (promoters, directors, KMPs, and their immediate relatives) reporting their own dealing in the company's securities, as NSE publishes them. Distinct from the SAST (Regulation 29 substantial-acquisition) filings on the market-wide SAST activity page. Public record only — this is descriptive disclosure data, not a signal, and is not a recommendation to buy or sell. Run python manage.py refresh_insider_trades --tickers CAPLIPOINT.NS to fetch more.

Ratios as of FY2025-26 (Annual) · Price ₹2560.80 INR (live) · fetched 2026-08-23 21:40 price stale

Extract this company (financials + ratios + citations): CSV · XLSX

Full statements: Profit & Loss · Balance Sheet · Cash Flow · Compare with 46 peers in Healthcare · Trace Score

Ratios

P/E
30.35
P/E = Price / EPS
Source trace
P/E = Price / (ProfitOrLossAttributableToOwnersOfParent / PaidUpValueOfEquityShareCapital ÷ FaceValueOfEquityShareCapital) → ₹2,560.80 / (₹6,412,400,000 / 76,000,000 shares) = ₹2,560.80 / ₹84.37 EPS
FY2025-26 · Annual filing
ROE
17.88%
ROE = Net Income / Shareholder Equity
Source trace
ROE = ProfitOrLossAttributableToOwnersOfParent / EquityAttributableToOwnersOfParent → ₹6,412,400,000 / ₹35,864,200,000 = 17.88%
FY2025-26 · Annual filing
Debt/Equity
0.00
Debt/Equity = Total Debt / Shareholder Equity
Source trace
Debt/Equity = BorrowingsCurrent + BorrowingsNoncurrent / EquityAttributableToOwnersOfParent → ₹5,700,000 / ₹35,864,200,000 = 0.00
FY2025-26 · Annual filing
Current Ratio
6.70
Current Ratio = Current Assets / Current Liabilities
Source trace
Current Ratio = CurrentAssets / CurrentLiabilities → ₹25,856,600,000 / ₹3,859,400,000 = 6.70
FY2025-26 · Annual filing
ROCE
22.40%
ROCE = EBIT / (Shareholder Equity + Total Debt)
Source trace
ROCE = ProfitBeforeExceptionalItemsAndTax + FinanceCosts / (EquityAttributableToOwnersOfParent + BorrowingsCurrent + BorrowingsNoncurrent) → ₹8,036,200,000 / (₹35,864,200,000 + ₹5,700,000) = 22.40%
FY2025-26 · Annual filing
Dividend Yield
0.23%
Dividend Yield = (Dividends Paid / Diluted Shares Outstanding) / Price

This is cash paid during the fiscal year, not a per-share rate declared for it (no such element exists in the filing data) — timing can straddle interim/final dividends across years, and pre-FY2020-21 figures may include the since-abolished Dividend Distribution Tax, reading higher than later years for that reason alone.

Source trace
Dividend Yield = (|DividendsPaidClassifiedAsFinancingActivities| / PaidUpValueOfEquityShareCapital ÷ FaceValueOfEquityShareCapital) / Price → (₹456,100,000 / 76,000,000 shares) / ₹2,560.80 = ₹6.00 / ₹2,560.80
FY2025-26 · Annual filing

Growth & earnings trend

Revenue & Profit CAGR

Revenue (3y, 3.0y actual) 14.2%
Net Profit (3y) 19.4%
Revenue (5y, 3.0y actual) 14.2%
Net Profit (5y) 19.4%
Revenue (10y, 3.0y actual) 14.2%
Net Profit (10y) 19.4%

Operating Margin Trend

Expanding

FY2022-23 30.8%
FY2023-24 33.3%
FY2024-25 35.0%
FY2025-26 36.7%

ROCE Trajectory

FY2022-23 23.7%
FY2023-24 24.1%
FY2024-25 23.5%
FY2025-26 22.1%

Earnings Quality

No persistent gap detected

Net Profit CAGR 19.44% vs CFO CAGR 24.41% over 3.0y (2023-03-31 → 2026-03-31); most recent year: Net Profit +13.82% vs CFO +21.01%

Sector-Relative Percentile (Healthcare)

ROE 72th
ROCE 72th
Debt/Equity 80th
P/E 78th

Quarterly trend

Revenue Net Profit Net Profit (loss quarter)
Metric (to shareholders basis) Q4 FY2023-24 Q1 FY2024-25 Q2 FY2024-25 Q3 FY2024-25 Q4 FY2024-25 Q1 FY2025-26 Q2 FY2025-26 Q3 FY2025-26 Q4 FY2025-26 Q1 FY2026-27 Source
Revenue ₹453.22 Cr. ₹458.96 Cr. ₹483.10 Cr. ₹492.96 Cr. ₹502.45 Cr. Gross ₹528.19 Cr. ₹510.22 Cr. Gross ₹533.36 Cr. ₹534.04 Cr. Gross ₹564.41 Cr. ₹542.77 Cr. Gross ₹576.45 Cr. ₹600.16 Cr. Gross ₹628.52 Cr. ₹610.36 Cr. Gross ₹643.91 Cr. RevenueFromOperations
Net Profit ₹121.59 Cr. incl. minority ₹121.23 Cr. ₹123.97 Cr. incl. minority ₹124.92 Cr. ₹130.80 Cr. incl. minority ₹130.81 Cr. ₹138.96 Cr. incl. minority ₹140.07 Cr. ₹140.82 Cr. incl. minority ₹145.28 Cr. ₹152.80 Cr. incl. minority ₹150.76 Cr. ₹154.45 Cr. incl. minority ₹160.23 Cr. ₹163.88 Cr. incl. minority ₹165.86 Cr. ₹170.11 Cr. incl. minority ₹172.88 Cr. ₹176.91 Cr. incl. minority ₹179.09 Cr. ProfitOrLossAttributableToOwnersOfParent

Primary figures are Revenue from Operations and Net Profit attributable to shareholders — the basis the ratios use. Where they differ, the companion Gross revenue (incl. inter-segment) and incl. minority net profit (the totals a news headline usually quotes) are shown beneath, each traceable to its own XBRL element. Quarters shown are however many are actually stored (up to 10) — run python manage.py refresh_quarterly_trend --tickers CAPLIPOINT.NS to fetch more.

Source document — income statement (FY2025-26, raw filing line items)

View original filing on NSE ↗ NSE's own filing document, opened in a new tab — StockProof links to it, never stores a copy.

ProfitOrLossAttributableToOwnersOfParent6412400000.0
PaidUpValueOfEquityShareCapital ÷ FaceValueOfEquityShareCapital76000000.0
Source document — balance sheet (FY2025-26, raw filing line items)

View original filing on NSE ↗ NSE's own filing document, opened in a new tab — StockProof links to it, never stores a copy.

CurrentAssets25856600000.0
CurrentLiabilities3859400000.0
EquityAttributableToOwnersOfParent35864200000.0
BorrowingsCurrent + BorrowingsNoncurrent5700000.0

My notes